Recommended Topic Related To:

Teslac

"Nov. 20, 2012 -- Although mammograms remain the gold standard for breast cancer screening, they are not the perfect test.

They don't find up to 30% of cancers, and they often find something that may be suspicious for cancer but really"...

Teslac

Discontinued Warning IconPlease Note: This Brand Name drug is no longer available in the US.
(Generic versions may still be available.)

Indications
Dosage
How Supplied

INDICATIONS

TESLAC (testolactone) is recommended as adjunctive therapy in the palliative treatment of advanced or disseminated breast cancer in postmenopausal women when hormonal therapy is indicated. It may also be used in women who were diagnosed as having had disseminated breast carcinoma when premenopausal, in whom ovarian function has been subsequently terminated.

TESLAC (testolactone) was found to be effective in approximately 15 percent of patients with advanced or disseminated mammary cancer evaluated according to the following criteria: 1) those with a measurable decrease in size of all demonstrable tumor masses; 2) those in whom more than 50 percent of non-osseous lesions decreased in size although all bone lesions remained static; and 3) those in whom more than 50 percent of total lesions improved while the remainder were static.

DOSAGE AND ADMINISTRATION

The recommended oral dose is 250 mg qid.

In order to evaluate the response, therapy with testolactone should be continued for a minimum of three months unless there is active progression of the disease.

HOW SUPPLIED

TESLAC® (testolactone tablets, USP), 50 mg/tablet: bottles of 100 (NDC 0003-0690-50). Each round, white, biconvex tablet is imprinted with the identification number 690.

Storage

Store at controlled room temperature 25°C (77°F).

Bristol-Myers Squibb Company, Princeton, NJ 08543 USA. Made in Australia. Revised May 2004

Last reviewed on RxList: 6/30/2009
This monograph has been modified to include the generic and brand name in many instances.

Indications
Dosage
How Supplied
A A A

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Breast Cancer

Find support and advances in treatment.